Owens & Minor, Inc. (NYSE:OMI – Get Free Report) has been assigned a consensus rating of “Hold” from the eight brokerages that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $18.50.
A number of analysts have commented on the stock. Robert W. Baird dropped their price target on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating on the stock in a research report on Tuesday, November 5th. Citigroup dropped their target price on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a report on Tuesday, November 5th. UBS Group cut their target price on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Finally, Barclays lowered their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th.
View Our Latest Analysis on OMI
Owens & Minor Stock Up 0.1 %
Owens & Minor (NYSE:OMI – Get Free Report) last released its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.01. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company had revenue of $2.72 billion for the quarter, compared to analysts’ expectations of $2.68 billion. During the same quarter in the previous year, the company posted $0.44 earnings per share. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, equities analysts expect that Owens & Minor will post 1.49 earnings per share for the current year.
Insider Buying and Selling
In related news, CFO Jonathan A. Leon sold 5,282 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the transaction, the chief financial officer now owns 130,822 shares of the company’s stock, valued at approximately $1,546,316.04. This trade represents a 3.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.62% of the company’s stock.
Hedge Funds Weigh In On Owens & Minor
Large investors have recently made changes to their positions in the business. Quarry LP grew its stake in Owens & Minor by 290.1% in the second quarter. Quarry LP now owns 2,099 shares of the company’s stock valued at $28,000 after purchasing an additional 1,561 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Owens & Minor by 176.8% during the 3rd quarter. Blue Trust Inc. now owns 2,787 shares of the company’s stock valued at $44,000 after buying an additional 1,780 shares during the last quarter. DekaBank Deutsche Girozentrale grew its stake in shares of Owens & Minor by 76.6% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company’s stock valued at $43,000 after buying an additional 1,356 shares in the last quarter. Canada Pension Plan Investment Board acquired a new position in Owens & Minor in the second quarter worth approximately $82,000. Finally, Meeder Asset Management Inc. increased its holdings in Owens & Minor by 844.1% in the third quarter. Meeder Asset Management Inc. now owns 9,016 shares of the company’s stock worth $141,000 after buying an additional 8,061 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Featured Stories
- Five stocks we like better than Owens & Minor
- P/E Ratio Calculation: How to Assess Stocks
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- The 3 Best Blue-Chip Stocks to Buy Now
- Oilfield Leader SLB: An AI Name You Need to Know
- What Are Some of the Best Large-Cap Stocks to Buy?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.